Free Trial

Helius Medical Technologies (HSDT) Competitors

Helius Medical Technologies logo
$0.91 +0.43 (+89.58%)
(As of 12/20/2024 05:45 PM ET)

HSDT vs. PSTV, INBS, TNON, NUWE, POAI, AEMD, CTCX, SINT, STSS, and CHEK

Should you be buying Helius Medical Technologies stock or one of its competitors? The main competitors of Helius Medical Technologies include Plus Therapeutics (PSTV), Intelligent Bio Solutions (INBS), Tenon Medical (TNON), Nuwellis (NUWE), Predictive Oncology (POAI), Aethlon Medical (AEMD), Carmell (CTCX), Sintx Technologies (SINT), Sharps Technology (STSS), and Check-Cap (CHEK). These companies are all part of the "medical equipment" industry.

Helius Medical Technologies vs.

Plus Therapeutics (NASDAQ:PSTV) and Helius Medical Technologies (NASDAQ:HSDT) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, community ranking and earnings.

Plus Therapeutics presently has a consensus target price of $13.50, indicating a potential upside of 1,138.53%. Helius Medical Technologies has a consensus target price of $24.00, indicating a potential upside of 2,537.36%. Given Helius Medical Technologies' higher probable upside, analysts clearly believe Helius Medical Technologies is more favorable than Plus Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Plus Therapeutics
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Helius Medical Technologies
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Helius Medical Technologies has lower revenue, but higher earnings than Plus Therapeutics. Plus Therapeutics is trading at a lower price-to-earnings ratio than Helius Medical Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Plus Therapeutics$4.91M1.31-$13.32M-$2.53-0.43
Helius Medical Technologies$502K6.76-$8.85M-$6.18-0.15

3.3% of Plus Therapeutics shares are owned by institutional investors. Comparatively, 18.6% of Helius Medical Technologies shares are owned by institutional investors. 5.5% of Plus Therapeutics shares are owned by insiders. Comparatively, 5.1% of Helius Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Helius Medical Technologies had 4 more articles in the media than Plus Therapeutics. MarketBeat recorded 6 mentions for Helius Medical Technologies and 2 mentions for Plus Therapeutics. Helius Medical Technologies' average media sentiment score of 0.25 beat Plus Therapeutics' score of -0.84 indicating that Helius Medical Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Plus Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative
Helius Medical Technologies
0 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Plus Therapeutics has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500. Comparatively, Helius Medical Technologies has a beta of 1.68, indicating that its stock price is 68% more volatile than the S&P 500.

Plus Therapeutics has a net margin of -225.07% compared to Helius Medical Technologies' net margin of -1,764.74%. Plus Therapeutics' return on equity of 0.00% beat Helius Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Plus Therapeutics-225.07% N/A -154.56%
Helius Medical Technologies -1,764.74%-244.82%-127.10%

Plus Therapeutics received 48 more outperform votes than Helius Medical Technologies when rated by MarketBeat users. Likewise, 62.39% of users gave Plus Therapeutics an outperform vote while only 55.56% of users gave Helius Medical Technologies an outperform vote.

CompanyUnderperformOutperform
Plus TherapeuticsOutperform Votes
68
62.39%
Underperform Votes
41
37.61%
Helius Medical TechnologiesOutperform Votes
20
55.56%
Underperform Votes
16
44.44%

Summary

Plus Therapeutics and Helius Medical Technologies tied by winning 9 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HSDT vs. The Competition

MetricHelius Medical TechnologiesElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$3.39M$3.07B$5.14B$9.08B
Dividend YieldN/A1.75%5.09%4.23%
P/E Ratio-0.1517.1690.0517.20
Price / Sales6.7650.221,117.09117.04
Price / CashN/A39.9143.1037.85
Price / Book0.273.724.784.78
Net Income-$8.85M$89.83M$120.31M$225.60M
7 Day Performance85.71%-1.76%-1.92%-1.23%
1 Month Performance102.22%-1.47%13.65%0.46%
1 Year Performance-89.15%-0.54%28.34%15.24%

Helius Medical Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HSDT
Helius Medical Technologies
2.6361 of 5 stars
$0.91
+89.6%
$24.00
+2,537.4%
-87.0%$3.39M$502,000.00-0.1530Short Interest ↓
Gap Up
High Trading Volume
PSTV
Plus Therapeutics
1.5574 of 5 stars
$1.17
-7.9%
$13.50
+1,054.4%
-42.3%$6.90M$4.91M-0.5020
INBS
Intelligent Bio Solutions
1.0388 of 5 stars
$1.46
-1.4%
N/A-68.7%$6.41M$3.19M0.0010Positive News
TNON
Tenon Medical
1.9628 of 5 stars
$1.94
-1.0%
$5.50
+183.5%
-0.5%$6.09M$2.93M-0.078Positive News
NUWE
Nuwellis
1.6403 of 5 stars
$1.19
+0.8%
$17.00
+1,328.6%
-95.0%$5.20M$8.86M-0.0159News Coverage
Positive News
POAI
Predictive Oncology
2.2425 of 5 stars
$0.73
-5.8%
$3.00
+308.6%
-76.7%$4.90M$1.48M-0.2530News Coverage
Gap Up
AEMD
Aethlon Medical
3.0781 of 5 stars
$0.35
-3.2%
$7.00
+1,917.3%
-69.3%$4.85M$570,000.00-0.1310Analyst Forecast
News Coverage
Gap Up
CTCX
Carmell
1.2731 of 5 stars
$0.21
-2.3%
N/A-94.5%$4.29M$32,839.000.0014News Coverage
Positive News
SINT
Sintx Technologies
0.4764 of 5 stars
$3.02
-2.6%
N/A-95.3%$4.06M$1.64M-0.0643
STSS
Sharps Technology
1.0349 of 5 stars
$2.09
+2.5%
N/AN/A$3.76MN/A-0.253News Coverage
Positive News
CHEK
Check-Cap
0.3448 of 5 stars
$0.62
-1.1%
N/A-71.4%$3.63MN/A-0.2180Analyst Forecast
News Coverage
Gap Down

Related Companies and Tools


This page (NASDAQ:HSDT) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners